Literature DB >> 2070558

Quantification of cross-reactive idiotype-positive rheumatoid factor produced in autoimmune rheumatic diseases. An indicator of clonality and B cell proliferative mechanisms.

F Shokri1, R A Mageed, G D Kitas, P Katsikis, H M Moutsopoulos, R Jefferis.   

Abstract

The aetiology of sustained autoantibody production in human autoimmune diseases is unknown. Evidence for structural similarities and common clonal origin among autoantibodies have been demonstrated through the expression of cross-reactive idiotype (CRI). In the present study we use four monoclonal antibodies (MoAbs) with specificity for non-overlapping CRI on human rheumatoid factor (RF) autoantibodies to define the structural features of polyclonal RF characteristic of patients with autoimmune rheumatic diseases. The pattern of CRI expression in the serum of 12 patients with rheumatoid arthritis (RA), eight with systemic lupus erythematosus (SLE) and 20 with primary Sjögren's syndrome and 34 normal individuals were determined in parallel with the level of IgM RF, IgA RF and autoantibodies to the cellular antigens SS-A, SS-B, Sm, nRNP and dsDNA and cryoglobulins. The results demonstrate significant elevation in the level of IgM and IgA expressing VHI (G6 and G8) and VHIII (B6 and D12) associated CRI in the serum of patients with autoimmune rheumatic diseases compared with normal individuals. These increases paralleled, but did not equal the increase in the level of immunoglobulins and RF. However, when expressed as proportion of immunoglobulin, only the VHI-associated CRI were significantly elevated in patients compared with normal individuals. The proportion of IgM RF expressing the VHI-associated CRI was higher in patients with Sjögren's syndrome compared with SLE and RA. Furthermore, the proportion of IgA RF expressing the G6 CRI was higher than G6+ IgM RF. These findings imply that different mechanisms contribute to RF production in autoimmune diseases. It is suggested that polyconal B cell activation is likely to be a contributing mechanism. However, such polyclonal activation is unlikely to be random since a selective elevation in the level of specific autoantibodies and VHI-associated CRI is observed. Furthermore, the data demonstrate that a proportion of autoantibodies in autoimmune diseases are immunoglobulin germline gene encoded. This is more evident in some patients with primary Sjögren's syndrome, where RF is likely to be oligoclonal or monoclonal in individuals with lymphoproliferation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2070558      PMCID: PMC1535709          DOI: 10.1111/j.1365-2249.1991.tb05676.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease.

Authors:  S Izui; P J McConahey; F J Dixon
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

2.  Preparation of F(ab')2 fragments from mouse IgG of various subclasses.

Authors:  E Lamoyi; A Nisonoff
Journal:  J Immunol Methods       Date:  1983-01-28       Impact factor: 2.303

3.  Diagnosis of gamma heavy-chain disease.

Authors:  E C Albutt; P C Hawker; K R Hine; B E Northam
Journal:  Ann Clin Biochem       Date:  1981-07       Impact factor: 2.057

4.  Immunofixation: application to the identification of "difficult" monoclonal components.

Authors:  E Pascali; A Pezzoli; A Chiarandini
Journal:  Clin Chem       Date:  1982-06       Impact factor: 8.327

5.  Increased risk of lymphoma in sicca syndrome.

Authors:  S S Kassan; T L Thomas; H M Moutsopoulos; R Hoover; R P Kimberly; D R Budman; J Costa; J L Decker; T M Chused
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

6.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

7.  Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.

Authors:  E L Alexander; T J Hirsch; F C Arnett; T T Provost; M B Stevens
Journal:  J Rheumatol       Date:  1982 Mar-Apr       Impact factor: 4.666

8.  Anti-human immunoglobulin G activity of membrane-bound monoclonal immunoglobulin M in lymphoproliferative disorders.

Authors:  J L Preud'homme; M Seligmann
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

9.  Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity.

Authors:  H G Kunkel; V Agnello; F G Joslin; R J Winchester; J D Capra
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  Similarities in the light chains of anti-gamma-globulins showing cross-idiotypic specificities.

Authors:  H G Kunkel; R J Winchester; F G Joslin; J D Capra
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

View more
  3 in total

1.  Rheumatoid factors in primary Sjögren's syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation.

Authors:  K E Elagib; M Børretzen; R Jonsson; H J Haga; J Thoen; K M Thompson; J B Natvig
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

2.  Hepatitis C virus infection in patients with essential mixed cryoglobulinemia, multiple myeloma and chronic lymphocytic leukemia.

Authors:  S Gharagozloo; J Khoshnoodi; F Shokri
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

3.  Effect of 51p1-related gene copy number (V1-69 locus) on production of hepatitis C-associated cryoglobulins.

Authors:  E H Sasso; P Ghillani; L Musset; J C Piette; P Cacoub
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.